Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment

Metabolic dysfunction–associated fatty liver disease (MAFLD) is nowadays considered the liver manifestation of metabolic syndrome. Its prevalence is increasing worldwide in parallel to the epidemic of diabetes and obesity. MAFLD includes a wide spectrum of liver injury including simple steatosis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sangro, Paloma, de la Torre Aláez, Manuel, Sangro, Bruno, D’Avola, Delia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635944/
https://www.ncbi.nlm.nih.gov/pubmed/36976456
http://dx.doi.org/10.1007/s13105-023-00954-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635944/
https://www.ncbi.nlm.nih.gov/pubmed/36976456
http://dx.doi.org/10.1007/s13105-023-00954-4

Ejemplares similares